Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P02754 (LACB_BOVIN) Bos taurus (Bovine)

Beta-lactoglobulin UniProtKBInterProSTRINGInteractive Modelling

178 aa; Sequence (Fasta) ; 1 identical sequence: Bos indicus x Bos taurus: A0A4W2BVI6

Available Structures

97 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of a Recombinant IgE Fab Fragment in Complex with Bovine Beta-Lactoglobulin Aller… Heteromer
20-178
LMT;
Assess
Bovine beta-lactoglobulin complex with myristic acidhomo-2-mer17-178
MYR;GOL;
Assess
Bovine beta-lactoglobulin variant A at pH 4.0homo-2-mer17-178
NO3;
Assess
Bovine beta-lactoglobulin complex with stearic acidhomo-2-mer17-178
STE;EOH;
Assess
Bovine beta-lactoglobulin complex with linoleic acidhomo-2-mer17-178
EIC;GOL;EOH;
Assess
Bovine beta-lactoglobulin (isoform B) in complex with dodecyltrimethylammonium (DTAC)homo-2-mer17-178
CAT;GOL;
Assess
Engineered beta-lactoglobulin: variant L58Fhomo-2-mer17-178
ACT;
Assess
Bovine beta-lactoglobulin (isoform A) in complex with lauric acid (C12)homo-2-mer17-178
DAO;
Assess
Bovine beta-lactoglobulin (isoform A) in complex with dodecyltrimethylammonium (DTAC)homo-2-mer17-178
CAT;
Assess
Bovine beta-lactoglobulin complex with tetracaine (BLG-TET)homo-2-mer17-178
TE4;
Assess
12-BROMODODECANOIC ACID BINDS INSIDE THE CALYX OF BOVINE BETA-LACTOGLOBULINhomo-2-mer17-178
BRC;
Assess
STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT …homo-2-mer17-178
Assess
Bovine beta-lactoglobulin (isoform A) in complex with dodecyl sulphate (SDS)homo-2-mer17-178
SDS;
Assess
Bovine beta-lactoglobulin (isoform B) in complex with dodecyl sulphate (SDS)homo-2-mer17-178
SDS;GOL;
Assess
Energetic and structural effects of the Tanford transition on the ligand recognition of bovine Beta…homo-2-mer17-178
SDS;
Assess
STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT …homo-2-mer17-178
Assess
Recombinant bovine beta-lactoglobulin variant L1A/I2S with endogenous ligand (sBlgB#1)homo-2-mer17-178
MYR;
Assess
Recombinant bovine beta-lactoglobulin with uncleaved N-terminal methionine (rBlgB)homo-2-mer17-178
GOL;MYR;SIN;
Assess
Bovine beta-lactoglobulin complex with dodecyl sulfatehomo-2-mer18-178
SDS;GOL;
Assess
Mutant I56F of recombinant bovine beta-lactoglobulin in complex with tetracainehomo-2-mer18-178
SO4;TE4;
Assess
Beta-lactoglobulin mutant FAW (I56F/L39A/M107W), unliganded formhomo-2-mer18-178
EDO;
Assess
Bovine lactoglobulin complex with decanolhomo-2-mer18-178
DE1;
Assess
Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (LG-LAF-CLP)homo-2-mer18-178
Z80;
Assess
Bovine beta-lactoglobulin complex with palmitic acidhomo-2-mer18-178
PLM;EOH;
Assess
Trigonal form of WT recombinant bovine beta-lactoglobulinhomo-2-mer18-178
EDO;EOH;
Assess
Mutant L39Y of recombinant beta-lactoglobulin in complex with endogenous ligandhomo-2-mer18-178
DAO;CL;
Assess
Bovine beta-lactoglobulin complex with lauric acidhomo-2-mer18-178
DAO;CL;
Assess
Bovine beta-lactoglobulin complex with oleic acidhomo-2-mer18-178
OLA;EOH;GOL;
Assess
Bovine beta-lactoglobulin complex with pramocaine crystallized from ammonium sulphate (BLG-PRM2)homo-2-mer18-178
PX9;
Assess
Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP)homo-2-mer18-178
Z80;PO4;
Assess
BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOIC ACID, TRIGONAL LATTICE Zhomo-2-mer18-178
REA;
Assess
BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL AND PALMITIC ACID, TRIGONAL LATTICE Zhomo-2-mer18-178
PLM;
Assess
BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL, TRIGONAL LATTICE Zhomo-2-mer18-178
RTL;
Assess
BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH PALMITATE, LATTICE Zhomo-2-mer18-178
PLM;
Assess
Mutant F105A of recombinant beta-lactoglobulin in complex with endogenous ligandhomo-2-mer19-178
DAO;SO4;
Assess
Mutant F105L of recombinant beta-lactoglobulinhomo-2-mer19-178
GOL;SO4;
Assess
Engineered beta-lactoglobulin: variant I56Fhomo-2-mer19-178
SO4;GOL;
Assess
Engineered beta-lactoglobulin: variant F105L in complex with myristic acidhomo-2-mer19-178
MYR;EDO;
Assess
Mutant L39Y-L58F of recombinant bovine beta-lactoglobulin in complex with pramocainehomo-2-mer19-178
PX9;SO4;
Assess
Mutant L39Y-L58F of recombinant bovine beta-lactoglobulin in complex with endogenous fatty acidhomo-2-mer19-178
DAO;EDO;SO4;CL;
Assess
Engineered beta-lactoglobulin: variant M107L in complex with myristic acidhomo-2-mer19-178
MYR;
Assess
Mutant L58F of recombinant bovine beta-lactoglobulin in complex with pramocainehomo-2-mer19-178
PX9;SO4;
Assess
Mutant L58F of recombinant bovine beta-lactoglobulin in complex with tetracainehomo-2-mer19-178
TE4;SO4;
Assess
Bovine beta-lactoglobulin crystallized in the presence of 2 mM zinc chloridehomo-2-mer19-178
ZN;
Assess
Mutant L39K of recombinant beta-lactoglobulin in complex with endogenous ligandhomo-2-mer19-178
DKA;EDO;
Assess
Beta-lactoglobulin (low humidity)homo-2-mer17-176
Assess
Engineered beta-lactoglobulin: variant L39Y in complex with endogenous ligandhomo-2-mer19-178
PLM;EDO;
Assess
Mutant L39Y of recombinant bovine beta-lactoglobulin in complex with pramocainehomo-2-mer19-178
PX9;SO4;CL;
Assess
Engineered beta-lactoglobulin: variant I56F-L39A in complex with chlorpromazine (LG-FA-CLP)homo-2-mer19-178
Z80;
Assess
Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#2)homo-2-mer20-178
EDO;DSM;SO4;CL;
Assess
Engineered beta-lactoglobulin: variant I56F-L39A-M107F in complex with chlorpromazine (LG-FAF-CLP)homo-2-mer20-178
Z80;SO4;GOL;PO4;CL;
Assess
Beta-lactoglobulin mutant FAF (I56F/L39A/M107F) in complex with desipramine (FAF-DSM)homo-2-mer20-178
DSM;GOL;CL;EDO;SO4;
Assess
Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#1)homo-2-mer20-178
SO4;DSM;CL;EDO;
Assess
Beta-lactoglobulin mutant FAF (I56F/L39A/M107F), unliganded formhomo-2-mer19-177
SO4;
Assess
Bovine beta-lactoglobulin crystallized in the presence of 20 mM zinc chloridehomo-2-mer20-178
ZN;
Assess
Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3)homo-2-mer20-177
DSM;EDO;SO4;CL;
Assess
Mutant M107L of recombinant bovine beta-lactoglobulin in complex with tetracainehomo-2-mer21-178
TE4;
Assess
The Cys121Ser Mutant of Beta-Lactoglobulinhomo-2-mer17-174
Assess
Engineered beta-lactoglobulin: variant M107Lhomo-2-mer19-176
GOL;PO4;
Assess
Bovin Beta-lactoglobulin binding with zinc ionshomo-2-mer22-178
ZN;
Assess
Recombinant bovine beta-lactoglobulin variant L1A/I2S (sBlgB#2)homo-2-mer17-173
Assess
The structure of bovine B-lactoglobulin A in crystals grown at very low ionic strengthhomo-2-mer21-176
Assess
HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORM A)homo-2-mer17-170
Assess
HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORMS A AND B) IN ORTHOROMBI…homo-2-mer17-168
Assess
Beta-lactoglobulin (native)homo-2-mer17-168
Assess
Engineered beta-lactoglobulin: variant F105Lhomo-2-mer17-168
Assess
Beta-lactoglobulin (reverse native)homo-2-mer17-168
Assess
Crystal structure of Gyuba, a patched chimera of b-lactglobulinhomo-2-mer34-170
Assess
Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo…monomer17-178
TDA;
Assess
Bovine beta-lactoglobulin complex with caprylic acidmonomer17-178
OCA;CL;
Assess
Bovine beta-lactoglobulin complex with capric acidmonomer17-178
DKA;GOL;CL;
Assess
Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo…monomer17-178
F15;CL;
Assess
Bovine beta-lactoglobulin complex with pramocaine crystallized from sodium citrate (BLG-PRM1)monomer17-178
PX9;
Assess
Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 18 h of soakingmonomer17-178
NH3;PT;
Assess
Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 72 h of soakingmonomer17-178
NH3;PT;
Assess
Bovine beta lactoglobulin unliganded formmonomer17-178
Assess
STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS OF VARIANTS A AND B OF BOVINE BETA-LACTOG…monomer17-178
Assess
Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo…monomer17-178
EW8;
Assess
Bovine beta-lactoglobulin complex with myristic acid at high pressure (0.55 GPa)monomer17-178
MYR;
Assess
STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT …monomer17-178
Assess
Crystal structure of beta-lactoglobulin complexed with chloroquinemonomer17-178
0TX;
Assess
Bovine beta-lactoglobulin complex with myristic acid, ambient pressuremonomer17-178
MYR;
Assess
Unliganded form of bovine beta-lactoglobulin, ambient pressuremonomer17-178
CL;
Assess
Bovine beta-lactoglobulin complex with dodecane at high pressure (0.43 GPa)monomer17-178
D12;CL;
Assess
Energetic and structural effects of the Tanford transition on the ligand recognition of bovine Beta…monomer18-178
SDS;
Assess
Beta-lactoglobulin in complex with Cp*Rh(III)Cl N,N-di(pyridin-2-yl)dodecanamidemonomer18-178
RHL;
Assess
Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo…monomer18-178
X90;
Assess
Crystal structure of a secondary vitamin D3 binding site of milk beta-lactoglobulinmonomer18-178
VD3;
Assess
Bovine beta lactoglobulin crytsallized through ligandation of yttriummonomer18-178
YT3;CL;
Assess
X.ray structure of the oxaliplatin/beta-lactoglobulin adductmonomer19-178
PT;
Assess
Engineered beta-lactoglobulin: variant L58F in complex with myristic acidmonomer19-178
MYR;SO4;
Assess
The structure of bovine beta-lactoglobulin in novel crystals grown at pH 3.8monomer18-177
CA;
Assess
BOVINE BETA-LACTOGLOBULIN Amonomer19-178
Assess
STRUCTURAL CHANGES ACCOMPANYING PH-INDUCED DISSOCIATION OF THE B-LACTOGLOBULIN DIMERmonomer19-178
Assess
Bovine beta lactoglobulin crystallized through ligandation of yttrium cationsmonomer20-178
YT3;CL;
Assess
Crystal structure of dha bind to bovine beta-lactoglobulinmonomer20-178
Assess
BOVINE BETA-LACTOGLOBULIN, LATTICE Xmonomer21-176
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6nkq.1.Amonomer0.8618-177
CA;100.00
Assess